Contribution of β-adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wild-type and β3-adrenoceptor knockout mice

被引:15
作者
Oostendorp, J
Preitner, F
Moffatt, J
Jimenez, M
Giacobino, JP
Molenaar, P [1 ]
Kaumann, AJ
机构
[1] Univ Queensland, Dept Med, Cardiovasc Res Unit, Prince Charles Hosp, Chermside, Qld 4032, Australia
[2] Babraham Inst, Cambridge CB2 4AT, England
[3] Ctr Med Univ Geneva, Dept Biochim Med, CH-1211 Geneva, Switzerland
[4] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia
[5] Univ Cambridge, Dept Physiol, Physiol Lab, Cambridge CB2 3EG, England
关键词
putative beta(4)-adrenoceptor; beta(1)- and beta(2)-adrenoceptors; beta(3)-adrenoceptor knockout mouse; colon; oesophagus; ureter; (-)-CGP 12177; (-)-[H-3]-CGP 12177; (-)-noradrenaline; (-)-adrenaline;
D O I
10.1038/sj.bjp.0703365
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The smooth muscle relaxant responses to the mixed beta(3)-, putative beta(4)-adrenoceptor agonist, (-)-CGP 12177 in rat colon are partially resistant to blockade by the beta(3)-adrenoceptor antagonist SR59230A suggesting involvement of beta(3)- and putative beta(4)-adrenoceptors. We now investigated the function of the putative beta(4)-adrenoceptor and other beta-adrenoceptor subtypes in the colon, oesophagus and ureter of wild-type (WT) and beta(3)-adrenoceptor knockout (beta(3)KO) mice. 2 (-)-Noradrenaline and (-)-adrenaline relaxed KCl (30 mM)-precontracted colon mostly through beta(1)-and beta(3)-adrenoceptors to a similar extent and to a minor extent through beta(2)-adrenoceptors. In colon from beta(3)KO mice, (-)-noradrenaline was as potent as in WT mice but the effects were mediated entirely through beta(1)-adrenoceptors. (-)-CGP 12177 relaxed colon from beta(3)KO mice with 2 fold greater potency than in WT mice. The maintenance of potency for (-)-noradrenaline and increase for (-)-CGP 12177 indicate compensatory increases in beta(1)- and putative beta(4)-adrenoceptor function in beta(3)KO mice. 3 In oesophagi precontracted with 1 mu M carbachol, (-)-noradrenaline caused relaxation mainly through beta(1)-and beta(3)-adrenoceptors. (-)-CGP 12177 (2 mu M) relaxed oesophagi from WT by 61.4+/-5.1% and beta(3)KO by 67.3+/-10.1% of the (-)-isoprenaline-evoked relaxation, consistent with mediation through putative beta(4)-adrenoceptors. 4 In ureter, (-)-CGP 12177 (2 mu M) reduced pacemaker activity by 31.1+/-2.3% in WT and 31.3+/-7.5% in beta(3)KO, consistent with mediation through putative beta(4)-adrenoceptors. 5 Relaxation of mouse colon and oesophagus by catecholamines are mediated through beta(1)- and beta(3)- adrenoceptors in WT. The putative beta(4)-adrenoceptor, which presumably is an atypical state of the beta(1)-adrenoceptor, mediates the effects of(-)-CGP 12177 in colon, oesophagus and ureter.
引用
收藏
页码:747 / 758
页数:12
相关论文
共 38 条
[21]   Action potential shortening through the putative β4-adrenoceptor in ferret ventricle:: comparison with β1- and β2-adrenoceptor-mediated effects [J].
Lowe, MD ;
Grace, AA ;
Vandenberg, JI ;
Kaumann, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (07) :1341-1344
[22]   Blockade of putative β4- and β1-adrenoceptors by carvedilol in ferret myocardium [J].
Lowe, MD ;
Grace, AA ;
Kaumann, AJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (05) :400-403
[23]   MODULATION OF NORADRENALINE RELEASE THROUGH ACTIVATION OF PRE-SYNAPTIC BETA-ADRENORECEPTORS [J].
MAJEWSKI, H .
JOURNAL OF AUTONOMIC PHARMACOLOGY, 1983, 3 (01) :47-60
[24]  
Manara L., 1995, PHARM COMMUN, V6, P253
[25]   Proposal for the interaction of non-conventional partial agonists and catecholamines with the 'putative beta(4)-adrenoceptor' in mammalian heart [J].
Molenaar, P ;
Sarsero, D ;
Kaumann, AJ .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (9-10) :647-656
[26]   Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta(3)-adrenoceptor and rodent intestinal beta(3)-adrenoceptors [J].
Molenaar, P ;
Sarsero, D ;
Arch, JRS ;
Kelly, J ;
Henson, SM ;
Kaumann, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (02) :165-176
[27]  
Munch G, 1996, BRIT J PHARMACOL, V118, P1855
[28]   PERIPHERAL MUSCARINIC CONTROL OF NOREPINEPHRINE RELEASE IN THE CARDIOVASCULAR-SYSTEM [J].
MUSCHOLL, E .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 239 (06) :H713-H720
[29]  
NANOFF C, 1987, N-S ARCH PHARMACOL, V336, P519
[30]   Anomalous behavior of CGP 12177A on beta(1)-adrenergic receptors [J].
Pak, MD ;
Fishman, PH .
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1996, 16 (1-2) :1-23